The Canadian Critical Care Trials Group (CCCTG) was created in 1989 to improve the care of critically ill patients through investigator-initiated research
The sixth trial result for #CCR25 in @TitanicBelfast in June is PROMIZING from @CCCTG_
Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation
#CCR25 - The Best Critical Care Trials in the World
Register via the QR code or on the CCR website
🎉We are thrilled to announce the activation of the King Abdulaziz Medical City site in 🇸🇦Saudi Arabia, led by Dr. Yaseen Arabi @YaseenarabiYa. This marks our first IMV domain site in Saudi Arabia and expands our trial to 6 countries.🎉
👀 Three @NEJM publications over the past six months. Warm CCCTG congratulations to our HEMOTION, BALANCE and SAHaRA colleagues on their outstanding dedication and teamwork!
Original Article: Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections (BALANCE) https://t.co/fAeAPSDZ4b
#CCCF2024 | @CCCForum
Presented at CCR Down Under:
In the SAHARA trial involving patients with subarachnoid hemorrhage and anemia, liberal transfusion of red cells did not result in a lower risk of an unfavorable neurologic outcome than a more restrictive strategy. https://t.co/WVobu2djnC
Aneurysmal SubArachnoid Hemorrhage - Red Blood Cell & Outcome (SAHaRA)
1ry:: Hb trigger ≤100g/L vs ≤80g/L in patients with aSAH and anemia (Hb≤100g/L) effects combined RoD/ disability
2ry: 12-m function and QoL b) mortality c) cerebral infarcts CT scans.
#CCRdownunder
Liberal or Restrictive Transfusion Strategy in Aneurysmal Subarachnoid Hemorrhage | New England Journal of Medicine - The SAHARA trial is now published in @nejm#ccrdownunder https://t.co/DGnvhpFUF2
Aneurysmal SubArachnoid Hemorrhage - Red Blood Cell & Outcome (SAHaRA)
No stat significant primary outcome difference between the 2 groups. (Hb trigger ≤100g/L vs ≤80g/L respectively)
#CCRdownunder